Skip to search formSkip to main contentSkip to account menu

Nuclear matrix protein 22

Known as: NMP22 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Nuclear Proteins
Nuclear matrix protein 22:ACnc:Pt:Urine:QnNuclear matrix protein 22:PrThr:Pt:Urine:Ord

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability.
Highly Cited
2007
Highly Cited
2007
Validation of the diagnostic value of NMP22 BladderChek test as a marker for bladder cancer by photodynamic diagnosis.
Highly Cited
2005
Highly Cited
2005
Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
PURPOSE We developed and validated nomograms that accurately predict disease recurrence and progression in patients with Ta, T1… 
Highly Cited
2002
Highly Cited
2002
Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Highly Cited
1999
Highly Cited
1999
Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat.
PURPOSE The limitation of current urinary tumor markers is the low specificity and positive predictive value, which clinically… 
Highly Cited
1999
Highly Cited
1999
NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer.
Highly Cited
1998
Highly Cited
1998
Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder.
Highly Cited
1997
Highly Cited
1997
Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer.
OBJECTIVES This study was undertaken to determine the clinical usefulness of nuclear matrix protein 22 (NMP22) as a novel urine… 
Highly Cited
1996
Highly Cited
1996
Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment.
Highly Cited
1996
Highly Cited
1996
Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)